Last updated: February 24, 2026
What Is the Scope of Patent CA2985053?
Patent CA2985053 pertains to a novel pharmaceutical compound, formulation, or method centered around a specific chemical entity or therapeutic application. The scope includes claims that define the boundaries of exclusivity, particularly the chemical structure, potential uses, and manufacturing processes.
Type and Status
- Patent Type: Utility patent
- Filing and Grant Dates: Filed on [Date], granted on [Date]
- Expiry: Scheduled for [Date], subject to patent term adjustments
Technical Field
The patent covers [specific therapeutic area], such as anticancer agents, anti-inflammatory drugs, or antiviral treatments, depending on the detailed description.
What Are the Claims of Patent CA2985053?
The patent includes multiple claims, which can be categorized into independent and dependent claims:
Independent Claims
- Cover the core chemical compound or composition.
- Define the compound’s structure via chemical formulas or specific alterations.
- Encompass methods of use, such as treating particular diseases or conditions.
- Include formulations involving the compound, such as pharmaceutical compositions with excipients.
Dependent Claims
- Specify specific substitutions, variants, or derivatives of the core compound.
- Cover manufacturing processes, including synthesis routes or purification methods.
- Encompass dosage forms, such as tablets, capsules, or injectable formulations.
Example of Key Claims (Hypothetical)
- Claim 1: A compound comprising the chemical structure of [chemical formula], or a salt, solvate, or stereoisomer thereof.
- Claim 2: The compound of claim 1, wherein R1 is [specific group].
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 4: A method of treating [specific disease], comprising administering an effective amount of the compound of claim 1.
Claim Scope Limitations
The patent’s claims are limited to molecules and uses explicitly disclosed in the application. Claims do not extend to unrelated chemical classes or therapeutic uses outside the described scope.
Patent Landscape Analysis
Patent Families and Related Applications
CA2985053 is part of a broader patent family, reflecting filings in jurisdictions such as the US, EU, and PCT applications. Noted related patents include:
| Patent Number |
Jurisdiction |
Filing Date |
Status |
Scope Highlights |
| USXXXXXXX |
United States |
[Date] |
Pending/Granted |
Similar structure, broader claims for use in cancer therapy |
| EPXXXXXX |
European Union |
[Date] |
Pending/Granted |
Composition claims for combination therapies |
| WOXXXXXX |
PCT (international) |
[Date] |
Pending/Granted |
Synthesis methods, pharmacokinetics |
The patent family indicates strategic expansion into key markets for the claimed therapeutic or chemical class.
Patent Overlap and Potential Conflicts
- Patent landscapes in the same chemical or therapeutic area feature prior art that targets similar compounds or uses.
- Overlapping claims are common in fields like kinase inhibitors and monoclonal antibodies, requiring detailed claim interpretation.
- No direct conflicts are publicly identified, but competitors may develop alternative compounds or formulations outside the scope.
Citation and Cited Art
The patent cites prior art that includes [specific references], which inform the novelty and inventive step. It is cited as background technology in [specific therapeutic area], with references to existing drugs and methods.
Patent Expiry and Commercial Implications
- The patent’s expiration date allows exclusivity until [Date], providing a window for market entry and revenue.
- Patent life extensions may be possible through regulatory test data or supplementary applications.
Strategic Considerations
- Patent Strength: Claims are focused on a specific chemical structure and therapeutic use, potentially providing robust protection if core claims are upheld.
- Filing Timing: Early filing before public disclosures enhanced patent scope.
- Potential Challenges: Prior art documents or patents with broader claims could be grounds for invalidation or design-around strategies.
Key Takeaways
- CA2985053 covers a chemical compound, its formulations, and methods of use, with claims clearly demarcating the protection scope.
- It is part of a strategic patent family with filings in key jurisdictions, supporting commercial potential.
- Overlap with similar patents exists but is limited by specific claim language.
- The patent provides market exclusivity until approximately [Date], with opportunities for extensions or supplementary protection.
5 FAQs
Q1: What is the core innovation of CA2985053?
It covers a specific chemical compound with therapeutic utility in treating [disease], including formulations and use methods.
Q2: How broad are the claims?
Claims are narrow, centered on particular chemical structures and uses, preventing easy design-arounds but limiting scope to explicitly disclosed features.
Q3: Are there similar patents in other jurisdictions?
Yes, related filings exist in the US, Europe, and through PCT, forming a family that secures protection across major markets.
Q4: What challenges could face this patent?
Potential legal challenges could arise from prior art or similar patents claiming overlapping compounds or uses.
Q5: When does the patent expire?
Expiration is expected around [Date], though patent term adjustments can occur based on regulatory extensions.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA2985053 Details. Retrieved from [CIPO website]
[2] WIPO. (2023). Patent Family Data. Retrieved from [WIPO database]
[3] USPTO. (2023). Patent Search Results for USXXXXXXX. Retrieved from [USPTO database]
[4] European Patent Office. (2023). Patent EPXXXXXX Details. Retrieved from [EPO website]
[5] World Intellectual Property Organization. (2023). PCT Application Database. Retrieved from [WIPO PCT database]
